Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Abstract

The Accreditation Sub-Committee of the EBMT regularly publishes special reports on current practice of haemopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders. Major changes have occurred since the last report in 1998. Haemopoietic stem cell transplantation today includes allogeneic and autologous stem cells derived from bone marrow, peripheral blood and cord blood. With reduced intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants. Other indications, such as autologous transplantation for breast cancer have been challenged. An updated report with revised tables and operating definitions is presented here.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schmitz N, Gratwohl A, Goldman JM . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1996 and proposals for an operational classification Bone Marrow Transplant 1996 17: 471 477

    CAS  Google Scholar 

  2. Goldman JM, Schmitz N, Niethammer D, Gratwohl A . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998 Bone Marrow Transplant 1998 21: 1 7

    Article  CAS  Google Scholar 

  3. Gratwohl A, Hermans J, Baldomero H et al. Indications for haemopoietic precursor cell transplants in Europe Br J Haematol 1996 92: 35 43

    Article  CAS  Google Scholar 

  4. Link H, Schmitz N, Gratwohl A, Goldman JM . Standards for specialist units undertaking blood and marrow stem cell transplants – recommendations from the EBMT Bone Marrow Transplant 1995 16: 733 763

    CAS  PubMed  Google Scholar 

  5. Joint Accreditation Committee EBMT-EuroISHAGE (JACIE) Accreditation Manual

Download references

Acknowledgements

The authors are grateful for the advice and helpful comments received from a number of individuals across Europe specialising in the use of haemopoietic stem cell transplantation to treat patients with haematological disorders. Special thanks to T Ruutu, JJ Ortega, G Sanz, F Prosper, E Montserrat, P Corradini and P Dreger.

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Urbano-Ispizua, A., Schmitz, N., de Witte, T. et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 29, 639–646 (2002). https://doi.org/10.1038/sj.bmt.1703535

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703535

Keywords

This article is cited by

Search

Quick links